info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_ASTROCYTOMA_EXALLC for full statistics.

Brain astrocytoma

C3_ASTROCYTOMA

astrocytoma: A glial tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, subependymal giant cell astrocytoma, and glioblastoma.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • HLP_C3_ASTROCYTOMA
143

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 C71
  • Cause of death: ICD-9 191
  • Cause of death: ICD-8 191
  • Cancer registry: Topography ICD-O-3 C71
  • Cancer registry: Morphology ICD-O-3 9400
  • Cancer registry: Behaviour codes 3

2 out of 7 registries used, show all original rules.

143

4. Check minimum number of events

None

143

5. Include endpoints

143

6. Filter based on genotype QC (FinnGen only)

143

Control definitions (FinnGen only)

Control conditions
not HLP_C3_ASTROCYTOMA

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF8

Similar endpoints

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 143 71 72
Unadjusted period prevalence (%) 0.03 0.02 0.03
Median age at first event (years) 40.83 38.49 43.14

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
135
Matched controls
1349
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
3628.2
123.3
100
*
L01AX03
ATC
temozolomide; systemic
+∞
112.9
92
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
199.2
109.3
106
24
130
Kela drug reimbursment
Malignant tumour
114.6
96.1
102
35
N03AX14
ATC
levetiracetam; systemic
226.5
82.1
78
8
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
+∞
77.8
67
*
H02AB02
ATC
dexamethasone; systemic
60.3
77.8
94
49
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
252.6
76.2
72
6
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
51.6
74.4
94
57
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
824.3
57.0
52
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
215.2
54.4
53
*
9400/3-C71.9
ICD-O-3
Astrocytoma, NOS, of brain, NOS
+∞
53.8
48
*
A04AA02
ATC
granisetron; systemic, transdermal
42.0
51.7
65
29
9400/3-C71.1
ICD-O-3
Astrocytoma, NOS, of frontal lobe
+∞
51.4
46
*
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
+∞
49.0
44
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
177.9
47.3
47
*
N03AF02
ATC
oxcarbazepine; oral
97.9
47.2
50
8
ZXC95
NOMESCO Finland
Use of surgical navigator
172.2
46.1
46
*
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
322.6
46.0
44
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
71.0
44.9
50
11
WF002
NOMESCO Finland
Radical radiotherapy
36.4
37.4
48
20
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
49.3
37.0
44
13
AA1AD
NOMESCO Finland
CT of head and brain
12.8
36.0
76
123
A03FA01
ATC
metoclopramide; systemic, rectal
12.0
34.9
77
134
XA800
NOMESCO Finland
Neuropsychological investigation
33.7
33.7
44
19
R56.8
ICD-10 Finland
Other and unspecified convulsions
21.4
33.5
51
37
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
+∞
32.6
30
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
72.0
29.7
33
6
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
29.2
27
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
15.9
28.1
48
45
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
116.8
26.8
28
*
N03AX18
ATC
lacosamide; systemic
+∞
24.7
23
*
XX3DW
NOMESCO Finland
Time consuming IT work
12.6
24.2
46
53
ZXC40
NOMESCO Finland
Use of ultrasound
79.7
23.8
26
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
27.5
23.5
32
15
N03AB02
ATC
phenytoin; systemic
274.7
23.4
23
*
9400/3-C71.2
ICD-O-3
Astrocytoma, NOS, of temporal lobe
+∞
22.5
21
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
8.6
22.4
55
100
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
21.4
20
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
130.3
21.3
22
*
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
+∞
20.3
19
*
A04AA01
ATC
ondansetron; systemic, rectal
13.1
19.4
35
35
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
52.1
18.9
22
5
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
77.5
18.3
20
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
109.7
18.1
19
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.2
17.8
75
260
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
58.2
17.5
20
*
WX882
NOMESCO Finland
High dependency care
32.4
17.1
22
8
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
+∞
15.9
15
*
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
180.0
15.8
16
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
90.2
14.9
16
*
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
14.9
14
*
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
167.4
14.8
15
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
167.4
14.8
15
*
N05BA09
ATC
clobazam; oral
83.5
13.9
15
*
C71.31
ICD-10 Finland
Malignant tumor of the parietal lobe grand II glioma
+∞
13.8
13
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
13.8
13
*
N03AG01
ATC
valproic acid; systemic, rectal
8.2
13.5
31
47
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
14.3
13.2
22
18
Z51.5
ICD-10 Finland
Palliative care
14.3
13.2
22
18
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
+∞
12.7
12
*
A02BC02
ATC
pantoprazole; systemic
4.0
12.5
100
559
H53.4
ICD-10 Finland
Visual field defects
41.8
12.5
15
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
51.6
12.1
14
*
N03AF01
ATC
carbamazepine; oral, rectal
11.2
11.8
22
23
C71.01
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade II glioma
+∞
11.6
11
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
11.6
11
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
+∞
11.6
11
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
65.3
10.8
12
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
+∞
10.5
10
*
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
+∞
10.5
10
*
C71.81
ICD-10 Finland
Overall malignant tumor of the brain grade II glioma
+∞
10.5
10
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
25.8
10.5
14
6
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
43.6
10.1
12
*
183
Kela drug reimbursment
Lamotrigin and topiramate
22.1
10.0
14
7
AA1BD
NOMESCO Finland
Extensive CT of head and brain
19.3
9.6
14
8
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
32.6
9.6
12
*
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
107.2
9.5
10
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.1
9.5
41
130
G40
ICD-10 Finland
Epilepsy
+∞
9.5
9
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
9.5
9
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
9.3
8.9
18
22
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
53.5
8.8
10
*
G40.10
ICD-10 Finland
Simple partial seizures
29.7
8.6
11
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
+∞
8.4
8
*
9400/3-C71.0
ICD-O-3
Astrocytoma, NOS, of cerebrum
+∞
8.4
8
*
WX872
NOMESCO Finland
Intensive care
7.8
8.1
18
26
WZC30
NOMESCO Finland
Teaching
4.5
7.9
29
78
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
47.8
7.8
9
*
ZXM40
NOMESCO Finland
Use of fluorescent substance
+∞
7.4
7
*
9400/3-C71.3
ICD-O-3
Astrocytoma, NOS, of parietal lobe
+∞
7.4
7
*
C71.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of brain
+∞
7.4
7
*
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
+∞
7.4
7
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
7.2
48
207
R47.0
ICD-10 Finland
Dysphasia and aphasia
42.2
6.8
8
*
N05CD08
ATC
midazolam; nasal, systemic
23.9
6.8
9
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
15.3
6.5
10
7
ZX070
NOMESCO Finland
Intensity modified radiotherapy
15.3
6.5
10
7
N03AX23
ATC
brivaracetam; systemic
73.2
6.5
7
*
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
73.2
6.5
7
*
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
73.2
6.5
7
*
WX402
NOMESCO Finland
General anaesthesia
3.4
6.4
34
123
AA5NK
NOMESCO Finland
Tractography within white matter of central nervous system
+∞
6.3
6
*
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
+∞
6.3
6
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
+∞
6.3
6
*
C71.13
ICD-10 Finland
Malignant tumor of frontal lobe grade IV glioma
+∞
6.3
6
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.7
6.1
27
86

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
82
91
19.78
75.19
1.4
1.4
—
—
—
0
0
70
101
12.62
51.47
5.5
13.6
0.8
1.9
mmol/l
1.95
51
77
50
52
14.25
45.83
4.0
4.1
23.8
25.1
mmol/l
1.50
50
52
22
16
16.07
24.19
2.0
1.4
—
—
—
0
0
107
470
6.07
22.10
6.7
7.9
1.2
1.2
mmol/l
1.21
95
400
18
15
13.58
18.15
1.8
1.3
—
—
—
0
0
84
351
4.38
17.17
2.2
2.2
—
—
—
0
0
29
53
6.61
16.00
5.9
11.1
96.4
94.8
%
1.88
29
53
91
422
4.18
15.64
3.3
2.0
—
—
—
0
0
22
33
7.70
14.48
1.9
1.6
—
—
—
0
0
100
528
3.97
13.51
3.3
4.2
—
—
—
0
0
78
357
3.61
13.00
4.0
7.2
1.0
1.2
inr
1.72
20
106
23
47
5.64
11.17
7.7
20.6
—
—
—
0
0
20
38
5.96
10.45
1.7
1.3
34.3
2.1
e6/l
1.24
14
28
20
38
5.96
10.45
1.8
1.4
1025.9
31.1
e6/l
0.48
15
30
111
692
3.70
10.33
16.6
9.7
3.4
4.0
e9/l
3.14
100
611
76
381
3.12
10.27
8.6
6.4
—
—
—
0
0
66
330
2.86
8.60
7.5
3.8
2.4
2.4
mmol/l
0.81
59
290
22
56
4.46
8.23
5.4
14.4
—
—
—
0
0
96
604
2.79
7.73
9.1
6.9
0.1
0.2
e9/l
9.54
85
548
94
587
2.75
7.65
9.2
6.3
0.0
0.0
e9/l
4.12
82
528
94
587
2.75
7.65
9.1
6.3
0.5
0.6
e9/l
0.71
83
525
90
559
2.65
7.26
9.4
6.7
9.3
8.5
%
1.64
90
540
88
543
2.61
7.16
9.3
6.6
0.5
0.7
%
3.85
88
518
89
554
2.61
7.08
9.2
6.4
2.1
2.8
%
3.47
89
533
90
569
2.57
6.84
9.3
6.3
60.0
57.2
%
1.18
90
549
93
608
2.51
6.42
9.3
6.4
1.4
1.8
e9/l
7.98
83
551
90
580
2.49
6.40
9.5
6.4
26.3
28.6
%
1.00
90
558
64
365
2.36
5.85
1.3
1.6
—
—
—
0
0
23
78
3.32
5.72
8.0
7.9
—
—
—
0
0
10
17
6.25
5.71
1.9
1.6
—
—
—
0
0
47
250
2.31
4.91
3.4
4.5
—
—
—
0
0
91
1139
0.45
4.80
2.8
3.8
4.8
4.7
mmol/l
0.48
81
1077
93
1151
0.45
4.62
2.9
4.0
3.0
2.9
mmol/l
0.74
81
1078
50
281
2.20
4.53
10.0
7.4
—
—
—
0
0
91
1133
0.46
4.52
2.8
3.7
1.4
1.4
mmol/l
0.45
81
1067
74
489
2.06
4.35
12.8
9.2
0.0
0.0
e9/l
0.39
62
403
44
244
2.16
4.07
3.2
3.5
—
—
—
0
0
58
363
2.01
3.86
2.7
3.1
13.8
32.9
ng/l
1.40
38
202
49
293
2.02
3.67
2.6
3.8
7.4
7.4
ph
—
9
51
20
81
2.71
3.65
3.4
4.9
—
—
—
0
0
89
1092
0.51
3.53
2.8
3.4
1.3
1.3
mmol/l
0.14
80
1018
6
8
7.76
3.08
1.5
1.8
—
—
—
0
0
99
1152
0.54
2.70
27.0
12.7
38.7
41.2
%
1.54
76
955
0
71
0.00
2.66
0.0
1.2
—
504.7
—
0
63
11
253
0.39
2.47
2.5
4.2
1.9
10.8
mg/mmol
—
5
166
10
34
3.09
2.46
3.0
6.6
—
—
—
0
0
0
55
0.00
2.12
0.0
1.1
—
—
—
0
0
85
1003
0.62
1.96
3.2
4.6
35.9
38.6
mmol/mol
4.17
74
960
5
11
4.67
1.95
1.4
1.1
93.0
91.9
%
—
5
11
93
1074
0.62
1.93
3.6
3.7
5.5
5.8
mmol/l
2.55
84
1000
7
22
3.29
1.90
3.1
2.4
8.8
9.1
kpa
—
7
22
7
22
3.29
1.90
3.1
2.4
5.2
5.0
kpa
—
7
22
7
22
3.29
1.90
3.1
2.4
2.3
2.5
mmol/l
—
7
15
17
87
2.08
1.89
3.8
3.4
1.8
1.0
%
—
9
24
6
19
3.25
1.68
2.8
2.6
—
—
—
0
0
30
437
0.60
1.66
3.2
2.9
—
—
—
0
0
127
1154
1.90
1.63
22.6
12.5
139.1
139.7
mmol/l
1.16
127
1126
127
1157
1.87
1.57
21.8
12.6
3.9
3.9
mmol/l
1.47
127
1126
10
195
0.48
1.47
1.3
1.3
—
—
—
0
0
7
146
0.45
1.42
1.0
1.2
—
—
—
0
0
10
192
0.48
1.41
1.8
1.4
—
—
—
0
0
34
464
0.65
1.37
1.9
2.3
—
—
—
0
0
98
1091
0.68
1.30
30.8
14.9
336.4
334.2
g/l
1.28
98
1086
128
1345
0.54
1.29
34.3
17.4
6.5
6.6
e9/l
0.07
128
1310
128
1344
0.55
1.24
34.3
17.4
90.7
90.2
fl
0.61
128
1328
128
1344
0.55
1.24
34.2
17.3
30.5
30.2
pg
1.43
128
1328
128
1344
0.55
1.24
35.3
17.5
135.9
138.9
g/l
1.68
128
1328
14
80
1.83
1.18
3.4
3.6
0.1
0.3
%
—
7
19
0
34
0.00
1.17
0.0
1.6
—
—
—
0
0
128
1342
0.56
1.16
34.3
17.4
246.4
251.7
e9/l
0.24
128
1310
28
381
0.67
1.08
1.9
1.9
—
—
—
0
0
13
211
0.58
1.07
1.3
1.7
—
—
—
0
0
36
272
1.43
1.01
2.2
2.6
—
—
—
0
0
11
183
0.57
0.99
2.3
2.7
0.8
0.8
ug/l
—
5
111
0
30
0.00
0.98
0.0
1.1
—
—
—
0
0
81
706
1.34
0.93
3.2
4.0
—
76.2
—
0
9
7
127
0.53
0.93
1.1
1.3
—
—
—
0
0
8
137
0.56
0.89
2.4
2.1
—
—
—
0
0
86
760
1.33
0.88
3.1
4.1
—
—
—
0
0
26
190
1.45
0.87
2.0
2.8
1867.0
722.6
ng/l
—
10
119
45
545
0.75
0.85
2.8
3.1
0.0
0.0
estimate
—
8
105
7
124
0.54
0.82
1.1
1.4
—
—
—
0
0
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
23
300
0.72
0.69
1.4
1.7
—
—
—
0
0
46
542
0.78
0.68
4.3
4.5
0.0
0.0
estimate
—
8
103
125
1187
1.42
0.66
20.1
11.8
19.6
21.0
mg/l
0.28
116
918
47
550
0.78
0.66
2.9
3.2
0.0
0.0
estimate
—
8
97
79
708
1.26
0.65
2.9
3.1
—
—
—
0
0
8
50
1.63
0.62
1.4
3.5
—
7.4
—
0
7
14
97
1.49
0.61
2.3
2.3
—
18.0
—
0
7
0
20
0.00
0.61
0.0
3.5
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
0
22
0.00
0.60
0.0
2.0
—
—
—
0
0
9
134
0.65
0.55
1.3
1.2
—
—
—
0
0
22
278
0.75
0.54
1.0
1.4
1.7
2.4
g/l
—
10
175
10
66
1.55
0.54
2.0
2.6
—
—
—
0
0
19
144
1.37
0.54
1.2
1.6
—
—
—
0
0
34
283
1.26
0.51
7.4
4.2
—
—
—
0
0
99
1051
0.81
0.50
3.9
4.4
1.7
1.7
mu/l
0.41
92
982
10
68
1.51
0.48
2.0
2.7
—
—
—
0
0
20
251
0.76
0.47
2.6
3.1
—
—
—
0
0
5
81
0.60
0.47
2.6
1.6
—
—
—
0
0
5
82
0.60
0.47
2.6
1.6
—
—
—
0
0
5
82
0.60
0.47
2.4
1.6
—
—
—
0
0
5
32
1.58
0.42
1.4
1.1
—
—
—
0
0
5
32
1.58
0.42
1.4
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
3.2
—
—
—
0
0
98
1034
0.83
0.41
28.7
14.3
13.4
13.4
%
0.18
98
1018
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
5
35
1.44
0.39
1.6
3.9
—
—
—
0
0
24
283
0.82
0.35
2.9
3.3
0.0
0.0
estimate
—
8
103
6
45
1.35
0.34
2.3
1.9
20.5
21.4
s
—
6
39
28
322
0.84
0.32
2.8
2.8
—
—
—
0
0
14
111
1.29
0.31
1.0
1.2
—
—
—
0
0
7
57
1.24
0.29
1.7
1.5
10.2
7.0
u/l
—
7
47
9
118
0.75
0.28
1.3
1.4
—
—
—
0
0
18
214
0.82
0.28
1.4
1.6
—
—
—
0
0
11
139
0.77
0.28
1.1
2.3
—
—
—
0
0
9
73
1.25
0.26
1.7
1.4
18.6
22.4
iu/l
—
9
65
48
520
0.88
0.25
2.0
2.6
91.0
90.3
ug/l
0.01
42
495
11
88
1.27
0.23
1.4
2.8
0.3
0.2
g/l
0.81
11
83
17
144
1.20
0.23
1.9
1.6
1369.3
1159.2
nmol/l
—
9
112
5
39
1.29
0.23
5.6
3.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
3.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
13.2
—
0
10
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
2.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
147.6
—
0
13
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
8.9
—
0.6
—
0
14
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
4.2
—
3.1
—
0
14
5
69
0.71
0.17
1.0
1.2
—
—
—
0
0
32
296
1.10
0.14
2.5
2.5
0.1
0.2
e6/l
0.12
24
219
8
96
0.82
0.14
1.0
1.3
—
150.2
iu/ml
—
0
31
37
395
0.91
0.14
2.8
3.1
49.5
48.1
e6/l
0.01
27
270
32
297
1.10
0.14
2.0
2.5
—
—
—
0
0
23
251
0.90
0.13
1.3
1.8
0.7
1.1
mg/l
1.08
13
194
6
54
1.12
0.09
1.2
1.1
—
—
—
0
0
10
88
1.15
0.08
1.7
4.3
—
—
—
0
0
8
90
0.88
0.07
2.4
3.3
—
—
—
0
0
83
842
0.97
0.04
3.6
3.9
14.3
14.5
pmol/l
0.31
77
787
12
128
0.93
0.02
1.2
1.7
—
—
—
0
0
126
1252
1.05
0.02
20.6
10.6
—
—
—
0
0
34
333
1.03
0.01
2.5
2.5
26.2
246.0
e6/l
0.59
26
257
127
1274
0.97
0.00
18.1
9.3
28.1
28.4
u/l
0.06
127
1250
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
5.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
36
360
1.00
0.00
1.7
1.8
99.2
99.8
pmol/l
0.03
19
181
0
6
0.00
0.00
0.0
9.7
—
—
—
0
0
6
68
0.88
0.00
2.0
2.3
10.1
6.2
ug/l
—
6
60
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
4.8
—
8.9
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: C3_ASTROCYTOMA – Brain astrocytoma

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).